MRNA vs GILD: Which Stock is Better?

Side-by-side comparison of Moderna Inc and Gilead Sciences Inc in 2026

Comparison Updated:

MRNA

Moderna Inc

$68.27

GILD

Gilead Sciences Inc

$129.83

Key Metrics Comparison

MetricMRNAGILDWinner
Market Cap$24.52B$160.15BGILD
P/E RatioN/A17.55GILD
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze MRNA

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MRNA or GILD a better investment?

Comparing MRNA and GILD: Moderna Inc has a market cap of $24.52B while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MRNA and GILD?

MRNA (Moderna Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MRNA or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MRNA or GILD?

Both MRNA and GILD show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: MRNA or GILD?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: MRNA or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $24.52B for MRNA.

Should I buy MRNA or GILD in 2026?

Both MRNA and GILD have investment merit. MRNA trades at $68.27 while GILD trades at $129.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MRNA and GILD stock?

Key differences: Market Cap ($24.52B vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy MRNA or GILD in 2026?

The choice between MRNA and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between MRNA and GILD?

MRNA (Moderna Inc) has a market cap of $24.52B, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.

Popular Stock Comparisons